(Q39473836)

12 September 2017

title

Surgical management of hypertrophic obstructive cardiomyopathy. Early and late results (English)

1 reference

hypertrophic obstructive cardiomyopathy

12 September 2017

main subject

0 references

author name string

Heric B

1

1 reference

12 September 2017

Lytle BW

2

1 reference

12 September 2017

Miller DP

3

1 reference

12 September 2017

Rosenkranz ER

4

1 reference

12 September 2017

Lever HM

5

1 reference

12 September 2017

Cosgrove DM

6

1 reference

12 September 2017

language of work or name

English

0 references

publication date

1 July 1995

1 reference

The Journal of Thoracic and Cardiovascular Surgery

12 September 2017

published in

1 reference

12 September 2017

volume

110

1 reference

12 September 2017

issue

1

1 reference

12 September 2017

page(s)

195-206; discussion 206-8

1 reference

Verapamil therapy: a new approach to the pharmacologic treatment of hypertrophic cardiomyopathy. I. Hemodynamic effects

12 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0022-5223%2805%2980026-1

Effects of sublingual nifedipine on hemodynamics and systolic and diastolic function in patients with hypertrophic cardiomyopathy.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-5223%2805%2980026-1

A double-blind, placebo-controlled crossover trial of nadolol and verapamil in mild and moderately symptomatic hypertrophic cardiomyopathy.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-5223%2805%2980026-1

Effects of amiodarone on erect and supine exercise haemodynamics and exercise capacity in patients with hypertrophic cardiomyopathy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-5223%2805%2980026-1

Improved survival with amiodarone in patients with hypertrophic cardiomyopathy and ventricular tachycardia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-5223%2805%2980026-1

Altered cardiac hemodynamic and electrical state in normal sinus rhythm after chronic dual-chamber pacing for relief of left ventricular outflow obstruction in hypertrophic cardiomyopathy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-5223%2805%2980026-1

Impact of dual-chamber permanent pacing in patients with obstructive hypertrophic cardiomyopathy with symptoms refractory to verapamil and beta-adrenergic blocker therapy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-5223%2805%2980026-1

Dual chamber pacing for hypertrophic obstructive cardiomyopathy: has its time come?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-5223%2805%2980026-1

Benefits of intraoperative echocardiography in the surgical management of hypertrophic cardiomyopathy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-5223%2805%2980026-1

Hypertrophic cardiomyopathy and intraoperative echocardiography: Too much of a good thing may be dangerous

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-5223%2805%2980026-1

Transesophageal Doppler echocardiography in obstructive hypertrophic cardiomyopathy: Clarification of pathophysiology and importance in intraoperative decision making

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-5223%2805%2980026-1

Long-term follow-up of patients undergoing myotomy/myectomy for obstructive hypertrophic cardiomyopathy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-5223%2805%2980026-1

Long-term follow-up of medical versus surgical therapy for hypertrophic cardiomyopathy: a retrospective study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-5223%2805%2980026-1

Current operative treatment of obstructive hypertrophic cardiomyopathy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-5223%2805%2980026-1

Hypertrophic cardiomyopathy: Prognosis with medical or surgical therapy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-5223%2805%2980026-1

Postoperative and long-term prognosis of myotomy-myomectomy for obstructive hypertrophic cardiomyopathy: influence of associated mitral valve replacement

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-5223%2805%2980026-1

Results of operation for coexistent obstructive hypertrophic cardiomyopathy and coronary artery disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-5223%2805%2980026-1

Amiodarone-induced complications after cardiac operation for obstructive hypertrophic cardiomyopathy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-5223%2805%2980026-1

Reoperation for persistent outflow obstruction in hypertrophic cardiomyopathy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-5223%2805%2980026-1

Aortic regurgitation: a common complication after surgery for hypertrophic obstructive cardiomyopathy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-5223%2805%2980026-1

Aortic regurgitation after left ventricular myotomy and myectomy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-5223%2805%2980026-1

Hypertrophic cardiomyopathy in the elderly. Distinctions from the young based on cardiac shape.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-5223%2805%2980026-1

Natural history of hypertrophic cardiomyopathy in the elderly

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-5223%2805%2980026-1

Prognosis in hypertrophic cardiomyopathy: role of age and clinical, electrocardiographic and hemodynamic features

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-5223%2805%2980026-1

Electrophysiologic abnormalities in patients with hypertrophic cardiomyopathy. A consecutive analysis in 155 patients

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-5223%2805%2980026-1

Relation between extent of left ventricular hypertrophy and occurrence of sudden cardiac death in hypertrophic cardiomyopathy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-5223%2805%2980026-1

Sudden death in hypertrophic cardiomyopathy. Assessment of patients at high risk

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-5223%2805%2980026-1

Comparison of clinical features in patients greater than or equal to 60 years of age to those less than or equal to 40 years of age with hypertrophic cardiomyopathy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-5223%2805%2980026-1

Mitral regurgitation due to ruptured chordae tendineae in patients with hypertrophic obstructive cardiomyopathy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-5223%2805%2980026-1

Anomalous insertion of papillary muscle directly into anterior mitral leaflet in hypertrophic cardiomyopathy. Significance in producing left ventricular outflow obstruction

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-5223%2805%2980026-1

Diversity of structural mitral valve alterations in hypertrophic cardiomyopathy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-5223%2805%2980026-1

Echocardiographic assessment of mitral valve size in obstructive hypertrophic cardiomyopathy. Anatomic validation from mitral valve specimen

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-5223%2805%2980026-1

Comparison of ventricular septal surgery and mitral valve replacement for hypertrophic obstructive cardiomyopathy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-5223%2805%2980026-1

Clinical and hemodynamic results after mitral valve replacement in patients with obstructive hypertrophic cardiomyopathy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-5223%2805%2980026-1

Appearance of or persistence of severe mitral regurgitation without left ventricular outflow obstruction after partial ventricular septal myotomy-myectomy in hypertrophic cardiomyopathy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-5223%2805%2980026-1

Effect of left ventricular septal myectomy on concurrent mitral regurgitation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-5223%2805%2980026-1

Comparison of Myectomy Alone or in Combination with Mitral Valve Repair for Hypertrophic Obstructive Cardiomyopathy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-5223%2805%2980026-1

Predictors of exercise benefit after operative relief of left ventricular outflow obstruction by the myotomy-myectomy procedure in hypertrophic cardiomyopathy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-5223%2805%2980026-1

Impact of surgical relief of outflow obstruction on thallium perfusion abnormalities in hypertrophic cardiomyopathy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-5223%2805%2980026-1

Effect of surgical reduction of left ventricular outflow obstruction on hemodynamics, coronary flow, and myocardial metabolism in hypertrophic cardiomyopathy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-5223%2805%2980026-1

Changes of the degree of hypertrophy in hypertrophic obstructive cardiomyopathy under medical and surgical treatment

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-5223%2805%2980026-1

10.1016/S0022-5223(05)80026-1

7 January 2021

Identifiers

DOI

1 reference

12 September 2017

1 reference